Companies / NuCana plc
NuCana plc
Nasdaq: NCNAForeign · IFRSCIK 1709626EDINBURGH
Ownership
20.81B shares outstanding
Ownership
| Institutions | <0.01% | 177,528 |
| Public float | 100.00% | 20,809,677,419 |
% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Bloss Jeffrey D.Chief Medical Officer | — | — |
Bruce Theresa Margaret MsChief Operating Officer | — | — |
Harrison David JamesHead of Translational Medicine | — | — |
Hugh S. GriffithCEOChief Executive Officer · Director | — | — |
Kay Andrew MartinDirector | — | — |
Leperlier CyrilleDirector | — | — |
Mellish Martin C.B.Director | — | — |
Webster Ian AlexanderSee Remarks | — | — |
Institutional holders 9
View all →| Holder | Value | % of shares |
|---|---|---|
| $480.0K | <0.01% | |
| $54.0K | <0.01% | |
| $40.8K | <0.01% | |
| $13.2K | <0.01% | |
| $5.2K | <0.01% | |
| $1.4K | <0.01% | |
| $378 | <0.01% | |
| $36 | <0.01% | |
| $0 | <0.01% |
Activity
Mar 31, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | Carlyle Group Inc. 13F manager | Exit | ADR | $-480.0K | -133K -100.00% | — | low |
| Q1 2026 as of | Rhumbline Advisers 13F manager | Trim | ADR | $-1.7K | -1K -24.18% | 3,722 <0.01% of shares | low |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| NCNA | ADR | 67022C304 |